Search results for "From ACP Internist Weekly"
Colonoscopies often recommended to patients with limited life expectancy
A study of patients ages 65 years and older found that 58.1% of those with life expectancy of less than five years and no polyps or only small hyperplastic polyps were told to return for future surveillance, as were 74.8% of those with life expectancy of five to 10 years.
https://gastroenterology.acponline.org/archives/2023/03/24/7.htm
24 Mar 2023
Guidelines update management of eosinophilic esophagitis
Recommendations from the American Gastroenterological Association and the Joint Task Force for Allergy-Immunology Practice Parameters cover use of proton-pump inhibitors, steroids, diets, and endoscopic dilation.
https://gastroenterology.acponline.org/archives/2020/05/22/6.htm
22 May 2020
Lipophilic statins associated with significantly reduced hepatocellular carcinoma incidence, mortality in hepatitis
Potential benefits of lipophilic statins appeared to be dose- and duration-dependent, with the greatest reduction in hepatocellular carcinoma risk seen with use of a moderate-dose statin for about two years, according to data from a registry of Swedish patients with hepatitis B or C.
https://gastroenterology.acponline.org/archives/2019/08/23/7.htm
23 Aug 2019
Model supports high-intensity surveillance after detection of colorectal adenomas
The target population was U.S. patients ages 50, 60, or 70 years with low-risk or high-risk adenomas removed after screening via colonoscopy or fecal immunochemical testing.
https://gastroenterology.acponline.org/archives/2019/09/27/10.htm
27 Sep 2019
6-food elimination diet may work for more than half of patients with eosinophilic esophagitis
Removing milk, wheat, soy, eggs, tree nuts/peanuts, and fish/shellfish from one's diet and then gradually reintroducing these food categories identified a single food trigger for 69% of participating patients with eosinophilic esophagitis, a retrospective study found.
https://gastroenterology.acponline.org/archives/2022/08/26/7.htm
26 Aug 2022
Financial incentives associated with increased FIT uptake but not increased CRC screening overall
A three-arm trial of incentives for fecal immunochemical testing (FIT) and colorectal cancer screening (CRC) tested mail-only, mail and monetary, and mail and lottery interventions.
https://gastroenterology.acponline.org/archives/2019/07/26/7.htm
26 Jul 2019
Task Force lowers age for colorectal cancer screening to begin
The U.S. Preventive Services Task Force recommended colorectal cancer screening begin at age 45 years based on an evidence review finding with moderate certainty that the net benefit is moderate to substantial.
https://gastroenterology.acponline.org/archives/2021/05/28/7.htm
28 May 2021
Response to linaclotide for IBS constipation can still appear after four weeks
An industry-funded analysis of four randomized trials of linaclotide for irritable bowel syndrome (IBS) with constipation found that improvement in abdominal and bowel symptoms occurred after four weeks of treatment in 1 in 6 and 1 in 10 patients, respectively.
https://gastroenterology.acponline.org/archives/2022/12/23/6.htm
23 Dec 2022
Apixaban associated with lower risk of GI bleeding compared to other DOACs
Apixaban users experienced similar rates of ischemic stroke or systemic embolism, intracranial hemorrhage, and all-cause mortality as patients taking other direct oral anticoagulants (DOACs), a retrospective analysis found.
https://gastroenterology.acponline.org/archives/2022/11/18/6.htm
18 Nov 2022
Continuing anti-TNF therapy in pregnancy appears beneficial for patients with IBD
A French target trial emulation, which refers to the use of observational data to mimic a randomized controlled trial, found that maternal relapse of inflammatory bowel disease (IBD) and premature births were less common when patients continued anti-tumor necrosis factor (anti-TNF) therapy after 24 weeks of pregnancy than when the drugs were discontinued.
https://gastroenterology.acponline.org/archives/2022/10/28/8.htm
28 Oct 2022